Cyclerion Therapeutics公司宣布与Medsteer达成一项战略合作协议,双方将携手推进其候选药物Cyc-126在难治性抑郁症治疗领域的研发进程。目前,公司在启动Cyc-126二期概念验证研究方面取得了显著进展,标志着该创新疗法向临床验证迈出了关键一步。
Cyclerion Therapeutics公司宣布与Medsteer达成一项战略合作协议,双方将携手推进其候选药物Cyc-126在难治性抑郁症治疗领域的研发进程。目前,公司在启动Cyc-126二期概念验证研究方面取得了显著进展,标志着该创新疗法向临床验证迈出了关键一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.